These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 15237)
21. Needed: new and better tools to combat latent tuberculosis infection. Blumberg HM Ann Intern Med; 2008 Nov; 149(10):761-3. PubMed ID: 19017594 [No Abstract] [Full Text] [Related]
22. Leukapheresis in the management of drug rash with eosinophilia and systemic symptoms syndrome. Martínez de Lagrán I; Marcos P; Batlle M; Alonso E; Plana A; Tomasa T Med Intensiva; 2017 Apr; 41(3):191-193. PubMed ID: 27017438 [No Abstract] [Full Text] [Related]
23. [Halothane and antituberculous drugs--a hepatotoxic combination? (author's transl)]. Schmidt-Wilcke HA; Wolfert W; Grundmann E Z Gastroenterol; 1977 Aug; 15(8):504-11. PubMed ID: 906600 [TBL] [Abstract][Full Text] [Related]
24. [Side effects of tuberculostatics (author's transl)]. Favez G; Wiser H Munch Med Wochenschr; 1973 Sep; 115(39):1685-90. PubMed ID: 4801051 [No Abstract] [Full Text] [Related]
25. Treatment of tuberculosis. McNicol M J R Coll Physicians Lond; 1979 Jan; 13(1):23-4. PubMed ID: 762670 [No Abstract] [Full Text] [Related]
26. [Characteristics of drug-induced hepatitis in patients with tuberculosis]. Vil'derman AM Probl Tuberk; 1972; 50(5):59-63. PubMed ID: 4112966 [No Abstract] [Full Text] [Related]
27. The side effects and interactions of antituberculosis drugs. Addington WW Chest; 1979 Dec; 76(6 Suppl):782-4. PubMed ID: 510025 [No Abstract] [Full Text] [Related]
28. Medical grand rounds from Touro Infirmary. Mycobacterium kansasii, aortic stenosis and antimicrobial related hepatitis. J La State Med Soc; 1975 Jun; 127(6):227-33. PubMed ID: 1151130 [No Abstract] [Full Text] [Related]
30. Hepatic toxicity during chemotherapy for severe tuberculosis meningitis. Donald PR; Schoeman JF; O'Kennedy A Am J Dis Child; 1987 Jul; 141(7):741-3. PubMed ID: 2884866 [TBL] [Abstract][Full Text] [Related]
31. [Value of enzyme tests in the diagnosis of toxic hepatocellular damage]. Chrostowski K; Milewski B Pol Tyg Lek; 1974 Oct; 29(41):1737-40. PubMed ID: 4154060 [No Abstract] [Full Text] [Related]
32. [The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids]. Kuntz HD; Rausch V; Bammel E Med Welt; 1978 Mar; 29(11):452-4. PubMed ID: 651600 [No Abstract] [Full Text] [Related]
33. Eczematous-type multiple drug allergy from isoniazid and ethambutol with positive patch test results. Özkaya E Cutis; 2013 Sep; 92(3):121-4. PubMed ID: 24153138 [TBL] [Abstract][Full Text] [Related]
34. [Apoptosis-inducing action of antituberculosis drugs of the main group in vitro]. Vasilyeva OA; Serebryakova VA; Urazova OI; Novitsky VV; Kononova TE; Naslednikova IO Antibiot Khimioter; 2010; 55(11-12):25-9. PubMed ID: 21574422 [TBL] [Abstract][Full Text] [Related]
35. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide]. Chioléro R Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521 [No Abstract] [Full Text] [Related]
36. The impact of chemotherapy on the care of patients with tuberculosis. Johnston RF; Wildrick KH Am Rev Respir Dis; 1974 Jun; 109(6):636-64. PubMed ID: 4209115 [No Abstract] [Full Text] [Related]